MedTrace Logo

Impact of COVID-19 on Sinus Augmentation Surgery

NCT05960136 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-07-27

No results posted yet for this study

Summary

The risk of Schneiderian membrane perforation and the postoperative complications of the sinus floor elevation surgery were evaluated for patients with and without history of COVID-19 infection.

Conditions

  • Bone Loss

Interventions

PROCEDURE

Sinus lift in patients with positive COVID-19 history

Sinus augmentation in the posterior atrophic maxilla in patients with positive COVID-19 history

PROCEDURE

Sinus lift with negative COVID-19 history

Sinus augmentation in the posterior atrophic maxilla in patients with negative COVID-19 history

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nahla Awadallah · Lecturer at Faculty of Dentistry, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-30
Primary Completion
2023-07-15
Completion
2023-07-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05960136 on ClinicalTrials.gov